Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

  • Stephanie R Earnshaw1Email author,
  • Cheryl L McDade1,
  • Giovanni Zanotti2,
  • Raymond A Farkouh3 and
  • David Strutton3
BMC Infectious Diseases201212:101

DOI: 10.1186/1471-2334-12-101

Received: 11 October 2011

Accepted: 24 April 2012

Published: 24 April 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Oct 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
16 Feb 2012 Reviewed Reviewer Report - Kristina Bryant
20 Feb 2012 Reviewed Reviewer Report - Maurizio de Martino
4 Mar 2012 Reviewed Reviewer Report - Paolo Bonanni
30 Mar 2012 Author responded Author comments - Stephanie Earnshaw
Resubmission - Version 3
30 Mar 2012 Submitted Manuscript version 3
Publishing
24 Apr 2012 Editorially accepted
24 Apr 2012 Article published 10.1186/1471-2334-12-101

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
RTI Health Solutions
(2)
Pfizer Canada Inc.
(3)
Pfizer Inc.

Advertisement